1. Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study. Issue 15 (9th May 2013) Authors: Karampeazis, Athanasios; Voutsina, Alexandra; Souglakos, John; Kentepozidis, Nikos; Giassas, Stelios; Christofillakis, Charalambos; Kotsakis, Athanasios; Papakotoulas, Pavlos; Rapti, Ageliki; Agelidou, Maria; Agelaki, Sofia; Vamvakas, Lambros; Samonis, George; Mavroudis, Dimitris; Georgoulias, Va... Journal: Cancer Issue: Volume 119:Issue 15(2013) Page Start: 2754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study. Issue 15 (9th May 2013) Authors: Karampeazis, Athanasios; Voutsina, Alexandra; Souglakos, John; Kentepozidis, Nikos; Giassas, Stelios; Christofillakis, Charalambos; Kotsakis, Athanasios; Papakotoulas, Pavlos; Rapti, Ageliki; Agelidou, Maria; Agelaki, Sofia; Vamvakas, Lambros; Samonis, George; Mavroudis, Dimitris; Georgoulias, Va... Journal: Cancer Issue: Volume 119:Issue 15(2013) Page Start: 2754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗